单价轮状病毒疫苗对多哥儿童急性胃肠炎住院影响的证据
多哥2014年6月将单价轮状病毒疫苗纳入免疫规划,研究比较引入前后急性胃肠炎及轮状病毒相关住院比例变化。哨点监测显示轮状病毒阳性率从引入前57%降至第一年42%、第二年26%;5家医院登记回顾显示<1岁组全因急性胃肠炎住院在引入后两个轮状病毒季节均下降48%。
要点
- 哨点监测轮状病毒阳性率由引入前57%降至引入后第一年42%、第二年26%。
- 5家医院登记回顾显示<1岁组全因急性胃肠炎住院在引入后两个季节均下降48%。
- 1-4岁组第一年未见下降,第二年下降19%。
核心结论
- 多哥引入单价轮状病毒疫苗后头两年,急性胃肠炎住院数及轮状病毒所致急性胃肠炎住院比例出现快速且明显下降。
- 作者认为有必要通过持续监测来评估疫苗对轮状病毒疾病负担的长期影响。
研究设计与样本
- 在首都洛美两个哨点开展<5岁儿童急性胃肠炎住院监测,急性胃肠炎定义为24小时内≥3次稀便或半稀便且持续<7天。
- 采用酶联免疫吸附试验(ELISA)诊断急性胃肠炎患儿的轮状病毒感染。
- 对5家医院住院登记进行回顾,评估<5岁儿童急性胃肠炎住院趋势。
- 比较疫苗引入前(2010年7月至2014年6月)与引入后(2014年7月至2016年6月)急性胃肠炎及轮状病毒相关住院比例的年度变化。
主要发现
- 疫苗引入前哨点监测纳入1017例患者,57%(范围53-62%)轮状病毒检测阳性;引入后第一年降至42%(下降23%),第二年降至26%(下降53%),婴儿中下降最明显。
- 住院登记回顾显示,与引入前轮状病毒季节相比,引入后两个轮状病毒季节<1岁组全因急性胃肠炎住院均下降48%。
- 1-4岁组第一年未见下降,第二年下降19%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Monovalent rotavirus vaccine (RV1) was introduced in the immunization schedule of Togo in June 2014. We evaluated the impact of rotavirus vaccines on acute gastroenteritis (AGE) and rotavirus-associated hospitalizations in Togolese children. METHODS: Sentinel surveillance for AGE (defined as ≥3 liquid or semi-liquid stools/24 h lasting <7 days) hospitalizations among children <5 years of age was conducted in two sites in the capital city, Lome. ELISA was used for diagnosis of rotavirus infection in children with AGE. Additionally, review of hospitalization registers was performed at five hospitals to assess trends in AGE hospitalizations among children aged <5 years. For the vaccine impact assessment, pre-rotavirus vaccine introduction (July 2010-June 2014) and post-rotavirus vaccine introduction (July 2014-June 2016) periods were compared for annual changes in proportions of hospitalizations associated with AGE and rotavirus. RESULTS: During the pre-vaccine period, sentinel surveillance showed that 1017 patients were enrolled and 57% (range, 53-62%) tested positive for rotavirus, declining to 42% (23% reduction) in the first post-vaccine year and to 26% (53% reduction) in the second post-vaccine year; declines were most marked among infants. The patient register review showed that, compared with pre-vaccine rotavirus seasons, declines in hospitalizations due to all-cause AGE during post-vaccine rotavirus seasons were 48% among <1 year age-group in both first and second years following vaccine introduction. Among 1-4 year olds no reduction was noted in the first year and a 19% decline occurred in the second year. CONCLUSIONS: We report rapid and marked reduction in the number of AGE hospitalizations and the proportion of AGE hospitalizations attributable to rotavirus in the first two years post- RV1 implementation in Togo. It is necessary to monitor long-term vaccine impact on rotavirus disease burden through continued surveillance.
引用
- Tsolenyanu E, Djadou KE, Fiawoo M, et al. Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo. Vaccine. 2018. PMID: 29397224. doi:10.1016/j.vaccine.2018.01.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。